Filters

2013 - 20144

More filters

20194
Reset filters

Settings

Subject: article × Start date: 2019 × End date: 2019 ×

Search Results

Now showing 1 - 4 of 4
  • Thumbnail Image
    Item
    Biofunctionalized self-propelled micromotors as an alternative on-chip concentrating system
    (Cambridge : Royal Society of Chemistry, 2014) Restrepo-Pérez, Laura; Meyer, Anne K.; Helbig, Linda; Sanchez, Samuel; Schmidt, Oliver G.
    Sample pre-concentration is crucial to achieve high sensitivity and low detection limits in lab-on-a-chip devices. Here, we present a system in which self-propelled catalytic micromotors are biofunctionalized and trapped acting as an alternative concentrating mechanism. This system requires no external energy source, which facilitates integration and miniaturization.
  • Thumbnail Image
    Item
    Proteinase-activated receptor-2 agonist activates anti-influenza mechanisms and modulates IFNγ induced antiviral pathways in human neutrophils
    (London : Hindawi, 2013) Feld, Micha; Shpacovitch, Victoria; Ehrhardt, Christina; Fastrich, Michaela; Goerge, Tobias; Ludwig, Stephan; Steinhoff, Martin
    Proteinase-activated receptor-2 (PAR2) is expressed by human leukocytes and participates in the development of inflammatory diseases. Recent studies demonstrated an ability of PAR2 agonist to enhance IFNγ-induced antiviral responses of human leukocytes. However, the precise cellular antiviral defense mechanisms triggered in leukocytes after stimulation with IFNγ and/or PAR2 agonist remain elusive. Therefore, we aimed to identify neutrophil defense mechanisms involved in antiviral resistance. Here we demonstrated that PAR2 agonist enhanced IFNγ-related reduction of influenza A virus (IAV) replication in human neutrophils. PAR2-mediated decrease in IAV replication was associated with reduced NS-1 transcription. Moreover, PAR2-dependent neutrophil activation resulted in enhanced myeloperoxidase degranulation and extracellular myeloperoxidase disrupted IAV. The production of ROS was elevated in response to PAR2 activation. Interestingly, IFNγ did not influence both effects: PAR2 agonist-triggered myeloperoxidase (MPO) release and reactive oxygen species (ROS) production, which are known to limit IAV infections. In contrast, orthomyxovirus resistance gene A (MxA) protein expression was synergistically elevated through PAR2 agonist and IFNγ in neutrophils. Altogether, these findings emphasize two PAR2-controlled antiviral mechanisms that are independent of or modulated by IFNγ.
  • Thumbnail Image
    Item
    Thermal activation of catalytic microjets in blood samples using microfluidic chips
    (Cambridge : Royal Society of Chemistry, 2013) Restrepo-Pérez, Laura; Soler, Lluís; Martínez-Cisneros, Cynthia S.; Sanchez, Samuel; Schmidt, Oliver G.
    We demonstrate that catalytic microjet engines can out-swim high complex media composed of red blood cells and serum. Despite the challenge presented by the high viscosity of the solution at room temperature, the catalytic microjets can be activated at physiological temperature and, consequently, self-propel in diluted solutions of blood samples. We prove that these microjets self-propel in 10× diluted blood samples using microfluidic chips.
  • Thumbnail Image
    Item
    Trapping self-propelled micromotors with microfabricated chevron and heart-shaped chips
    (Cambridge : Royal Society of Chemistry, 2014) Restrepo-Pérez, Laura; Soler, Lluís; Martínez-Cisneros, Cynthia S.; Sanchez, Samuel; Schmidt, Oliver G.
    We demonstrate that catalytic micromotors can be trapped in microfluidic chips containing chevron and heart-shaped structures. Despite the challenge presented by the reduced size of the traps, microfluidic chips with different trapping geometries can be fabricated via replica moulding. We prove that these microfluidic chips can capture micromotors without the need for any external mechanism to control their motion.